Brief: Australian Clinical Labs Ltd Says Update On Offer For Healius
Sept 14 (Reuters) - Australian Clinical Labs Ltd
ACL.AX :
* UPDATE ON OFFER FOR HEALIUS AND POSTPONEMENT OF EGM,HLS
* ACL CONTINUES TO BELIEVE THAT PROPOSED MERGER IS MOST
VALUE
ACCRETIVE OPTION FOR HEALIUS AND ACL SHAREHOLDERS
Source text for Eikon: ID:nASX17NnG9
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million